The Journal of Heart and Lung Transplantation
Volume 25, Issue 3 , Pages 294-297 , March 2006

Donor or Recipient Hepatitis B Seropositivity Is Associated With Allograft Vasculopathy

  • Showkat A. Haji, MD

      Affiliations

    • Department of Cardiology, Tulane University Medical Center, New Orleans, Louisiana
    • Corresponding Author InformationReprint requests: Showkat A Haji, MD, Tulane University Medical Center, 1430 Tulane Avenue, SL48, New Orleans, LA 70112. Telephone: 504-988-5263
    • ,
  • Robin K. Avery, MD

      Affiliations

    • Department of Infectious Disease, Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • ,
  • Mohamad H. Yamani, MD

      Affiliations

    • Department of Cardiovascular Medicine, Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • ,
  • E. Murat Tuzcu, MD

      Affiliations

    • Department of Cardiovascular Medicine, Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • ,
  • Timothy D. Crowe, MS

      Affiliations

    • Department of Cardiovascular Medicine, Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • ,
  • Daniel J. Cook, PhD

      Affiliations

    • Allogen Laboratory, Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • ,
  • Steven D. Mawhorter, MD

      Affiliations

    • Department of Infectious Disease, Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • ,
  • Robert Hobbs, MD

      Affiliations

    • Department of Cardiovascular Medicine, Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • ,
  • James B. Young, MD

      Affiliations

    • Department of Cardiovascular Medicine, Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • ,
  • Nicholas Smedira, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio
    • ,
  • Randall C. Starling, MD MPH

      Affiliations

    • Department of Cardiovascular Medicine, Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio, USA

Received 14 June 2005 ,Revised 18 August 2005 ,Accepted 13 October 2005.

References 

  1. Valantine HA . The role of viruses in cardiac allograft vasculopathy . Am J Transplant . 2004;4:169–177
  2. Kocher AA , Bonaros N , Dunkler D , et al.   Long-term results of CMV hyperimmune globulin prophylaxis in 377 heart transplant recipients . J Heart Lung Transplant . 2003;22:250–257
  3. Luckraz H , Charman SC , Wreghitt T , Wallwork J , Parameshwar J , Large SR . Does cytomegalovirus status influence acute and chronic rejection in heart transplantation during the ganciclovir prophylaxis era? . J Heart Lung Transplant . 2003;22:1023–1027
  4. Shirali GS , Ni J , Chinnock RE , et al.   Association of viral genome with graft loss in children after cardiac transplantation . N Engl J Med . 2001;344:1498–1503
  5. Haji SA , Starling RC , Avery RK , et al.   Donor hepatitis C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation . J Heart Lung Transplant . 2004;23:277–283
  6. Guillevin L . Virus-associated vasculitides . Rheumatology (Oxford) . 1999;38:588–590
  7. Ishizaka N , Ishizaka Y , Takahashi E , et al.   Increased prevalence of carotid atherosclerosis in hepatitis B carriers . Circulation . 2002;105:1028–1030
  8. Lunel F , Cadranel JF , Rosenheim M , et al.   Hepatitis virus infections in heart transplant recipients (epidemiology, natural history, characteristics, and impact on survival) . Gastroenterology . 2000;119:1064–1074
  9. Tuzcu E , Hobbs R , Rincon G , et al.   Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation . Circulation . 1995;91:1706–1713
  10. Costanzo MR , Naftel DC , Pritzker MR , et al.  Cardiac Transplant Research Database   Heart transplant coronary artery disease detected by coronary angiographys (a multiinstitutional study of preoperative donor and recipient risk factors) . J Heart Lung Transplant . 1998;17:744–753
  11. Rickenbacher PR , Pinto FJ , Chenzbraun A , et al.   Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound . JAMA . 1995;25:171–177
  12. Tuzcu EM , De Franco AC , Goormastic M , et al.   Dichotomous pattern of coronary atherosclerosis 1 to 9 years after transplantations (insights from systematic intravascular ultrasound imaging) . JAMA . 1996;27:839–846
  13. Libby P , Salomon RN , Payne DD , Schoen FJ , Pober JS . Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis . Transplant Proc . 1989;21:3677–3684
  14. Hauptman PJ , Davis SF , Miller L , Yeung AC  Multicenter Intravascular Ultrasound Transplant Study Group . The role of nonimmune risk factors in the development and progression of graft arteriosclerosiss (preliminary insights from a multicenter intravascular ultrasound study) . J Heart Lung Transplant . 1995;14:S238–S242
  15. Day JD , Rayburn BK , Gaudin PB , et al.   Cardiac allograft vasculopathys (the central pathogenetic role of ischemia-induced endothelial cell injury) . J Heart Lung Transplant . 1995;14:S142–S149
  16. Costanzo-Nordin MR . Cardiac allograft vasculopathys (relationship with acute cellular rejection and histocompatibility) . J Heart Lung Transplant . 1992;11:S90–S103
  17. Cramer DV , Qian SQ , Harnaha J , et al.   Cardiac transplantation in the rat. I . The effect of histocompatibility differences on graft arteriosclerosis Transplantation . 1989;47:414–419
  18. Gao SZ , Schroeder JS , Alderman EL , et al.   Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient . Circulation . 1987;76:V56–V61
  19. Grattan MT , Moreno-Cabral CE , Starnes VA , Oyer PE , Stinson EB , Shumway NE . Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis . JAMA . 1989;261:3561–3566
  20. Radovancevic B , Birovljev S , Vega JD , et al.   Inverse relationship between human leukocyte antigen match and development of coronary artery disease . Transplant Proc . 1991;23:1144–1145
  21. Rose EA , Pepino P , Barr ML , et al.   Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients . J Heart Lung Transplant . 1992;11:S120–S123
  22. Wachs ME , Amend WJ , Ascher NL , et al.   The risk of transmission of hepatitis B from HBsAg (−), HBcAb (+), HBIgM (−) organ donors . Transplantation . 1995;59:230–234
  23. Pinney SP , Cheema FH , Hammond K , et al.   Acceptable outcomes with the use of hearts from donors with hepatitis-B core antibodies . J Heart Lung Transplant . 2005;24:34–37
  24. Chung RT , Feng S , Delmonico FL . Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor . Am J Transplant . 2001;1:185–191

PII: S1053-2498(05)00756-4

doi: 10.1016/j.healun.2005.10.007

The Journal of Heart and Lung Transplantation
Volume 25, Issue 3 , Pages 294-297 , March 2006

Article Tools